4 1 d4.txt FORM 4 FOR JOHN HOWE /------------------------------/ / OMB APPROVAL / /------------------------------/ / OMB Number: 3235-0287 / / Expires: September 30, 1998 / / Estimated average burden / / hours per response...... 0.5 / /------------------------------/ +--------+ | FORM 4 | U.S. SECURITIES AND EXCHANGE COMMISSION +--------+ Washington, D.C. 20549 [_] Check this box if no longer subject STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP to Section 16. Form 4 or Form 5 Filed pursuant to Section 16(a) of the Securities obligations may Exchange Act of 1934, Section 17(a) of the continue. See Public Utility Holding Company Act of 1935 or Instruction 1(b). Section 30(f) of the Investment Company Act of 1940 (Print or Type Responses) -------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* Howe John F. -------------------------------------------------------------------------------- (Last) (First) (Middle) 46107 Landing Parkway -------------------------------------------------------------------------------- (Street) Fremont, CA 94538 -------------------------------------------------------------------------------- (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol VidaMed, Inc. (VIDA) ----------------------------------- 3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary) ---------------------------------------------------------------- 4. Statement for Month/Year February 2002 --------------------------------------------------- 5. If Amendment, Date of Original (Month/Year) --------------------------------- 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) [_] Director [X] Officer [_] 10% Owner [_] Other (give title below) (specify below) Vice President Finance & Chief Financial Officer ---------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check applicable line) X Form filed by One Reporting Person ---- ____ Form filed by More than One Reporting Person Table I--Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the Form is filed by more than one reporting person, see Instruction 4(b)(v). Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. (Over) SEC 1474(7-97)

Explanation of Responses: (1) 25% of the option becomes exercisable within one year of the grant date, 8/23/99, and 1/48th per month thereafter until fully exercised /s/ John F. Howe 3/4/02 -------------------------------------------- ------------------------- ** Signature of Reporting Person Date ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. Page 2 SEC 1474(7-97)

VIDAMED INC 4